IL138939A0 - A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof - Google Patents

A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Info

Publication number
IL138939A0
IL138939A0 IL13893999A IL13893999A IL138939A0 IL 138939 A0 IL138939 A0 IL 138939A0 IL 13893999 A IL13893999 A IL 13893999A IL 13893999 A IL13893999 A IL 13893999A IL 138939 A0 IL138939 A0 IL 138939A0
Authority
IL
Israel
Prior art keywords
truncate
polypeptide
amino acid
binding protein
derived therefrom
Prior art date
Application number
IL13893999A
Other languages
English (en)
Original Assignee
St Jude Childrens Res Hospital
Medimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St Jude Childrens Res Hospital, Medimmune Inc filed Critical St Jude Childrens Res Hospital
Publication of IL138939A0 publication Critical patent/IL138939A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13893999A 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof IL138939A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PCT/US1999/007669 WO1999051188A2 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
IL138939A0 true IL138939A0 (en) 2001-11-25

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13893999A IL138939A0 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Country Status (14)

Country Link
JP (1) JP4739521B2 (enExample)
KR (1) KR100638503B1 (enExample)
CN (1) CN1191851C (enExample)
AU (2) AU764811B2 (enExample)
BR (1) BR9909910A (enExample)
CA (1) CA2326388C (enExample)
HU (1) HUP0102306A3 (enExample)
IL (1) IL138939A0 (enExample)
MX (1) MXPA00009899A (enExample)
NO (1) NO20005081L (enExample)
NZ (1) NZ507983A (enExample)
PL (1) PL193132B1 (enExample)
TR (1) TR200003498T2 (enExample)
WO (1) WO1999051188A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
DK2384765T3 (en) 2005-12-22 2017-01-09 Glaxosmithkline Biologicals Sa Vaccine against Streptococcus pneumoniae.
EP2687228B1 (en) 2007-06-26 2017-07-19 GlaxoSmithKline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
ES2678694T3 (es) 2008-04-16 2018-08-16 Glaxosmithkline Biologicals Sa Vacuna
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
WO2012156391A1 (en) 2011-05-17 2012-11-22 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
JP2000511411A (ja) * 1996-05-01 2000-09-05 ザ ロックフェラー ユニヴァーシティ 抗―肺炎球菌ワクチン用のコリン結合タンパク質
US6420135B1 (en) * 1996-10-31 2002-07-16 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
EP0942984A2 (en) * 1996-11-12 1999-09-22 Regents Of The University Of Minnesota C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
CN1200731C (zh) * 1998-04-07 2005-05-11 免疫医疗公司 用作疫苗的肺炎球菌胆碱结合蛋白衍生物

Also Published As

Publication number Publication date
JP4739521B2 (ja) 2011-08-03
TR200003498T2 (tr) 2001-10-22
WO1999051188A2 (en) 1999-10-14
MXPA00009899A (es) 2002-05-08
HUP0102306A1 (hu) 2001-09-28
PL347946A1 (en) 2002-04-22
AU3479799A (en) 1999-10-25
NO20005081D0 (no) 2000-10-09
CN1342088A (zh) 2002-03-27
JP2002516662A (ja) 2002-06-11
WO1999051188A9 (en) 2000-10-12
PL193132B1 (pl) 2007-01-31
HUP0102306A3 (en) 2008-04-28
NZ507983A (en) 2004-03-26
NO20005081L (no) 2000-12-06
BR9909910A (pt) 2002-01-15
CA2326388C (en) 2014-02-04
AU3479699A (en) 1999-10-25
CA2326388A1 (en) 1999-10-14
AU764811B2 (en) 2003-08-28
KR100638503B1 (ko) 2006-10-26
CN1191851C (zh) 2005-03-09
KR20010052244A (ko) 2001-06-25
WO1999051188A3 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
IL134523A0 (en) Interleukin-18 binding proteins, their preparation and use
WO2000023472A3 (en) Interferon-beta fusion proteins and uses
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
GB9923048D0 (en) Composition comprising casein protein and whey protein
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
ZA200006309B (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof.
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
HUP0102306A3 (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
EP1080182A4 (en) AMINO ACID MODIFIED POLYPEPTIDES
EP1109454A4 (en) NEISSERIA MENINGITIDIS POLYPEPTID, NUCLEIC ACID SEQUENCE AND USES THEREOF
AU2002233457A1 (en) Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
GB9918155D0 (en) Proteins and peptides
EP1177212A4 (en) LAWSONIA DERIVATIVE GENE AND RELATED POLYPEPTIDES, PEPTIDES AND SODC PROTEINS, AND USES THEREOF
PL343554A1 (en) Novel peptide diagnostic reagent and kit for detection of rickettsiosis
EP1177213A4 (en) LAWSONIA DERIVATIVE GENE, POLYPEPTIDES, PEPTIDES AND HEMOLYSIN PROTEINS AND USES THEREOF
EP1080185A4 (en) BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
CA2259640A1 (en) Human glycine transporter
GB2336844B (en) Anti-hiv peptides and proteins
CA2163805A1 (en) Novel activating factor of leukocytes
WO2004089973A3 (en) Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
AU7282498A (en) Bioactive peptides derived from cocaine and amphetamine regulated transcript protein
EP0911408A3 (en) DNA coding for serine/threonine kinase
AU5495500A (en) Decorin binding protein essential peptides and methods of use
AU8557801A (en) Modified proteins, isolated novel peptides, and uses thereof
WO2003018806A1 (fr) Nouveau gene humain bmcc1